Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease.
Location: United States, California, Menlo Park
Employees: 201-500
Total raised: $103M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | KCK Medtec... | kckmedtech... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 18.03.2020 | Series E | $30M | - |
| 05.09.2019 | Series D | $56M | - |
| 09.10.2017 | Series C | $10M | - |
| 15.03.2016 | Series B | $7M | - |
Mentions in press and media 15
| Date | Title | Description |
| 07.03.2024 | Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance | - |
| 14.07.2021 | Sight Sciences Bulks Up IPO, Targeting $1 Billion Valuation | One day before it is scheduled to list its shares, Sight Sciences boosted the size of its initial public offering by 43% and increased the price range for the deal. The eye device company said in a prospectus on Wednesday it would sell 10 m... |
| 04.03.2021 | Sight Sciences Receives FDA Clearance for Expanded Indication for OMNI Surgical System | |
| 01.12.2020 | Sight Sciences Announces Substantial Crossover Raise | |
| 09.09.2020 | Sight Sciences Presents Additional Results of OLYMPIA Study Demonstrating Successful Treatment of Signs and Symptoms of Dry Eye Disease Using TearCare | |
| 18.03.2020 | Sight Sciences Raises $30M in Series E Funding | Sight Sciences, Inc., a Menlo Park, CA-based growth-stage medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed an over $30m Series E Preferred Stock financing round. The round was led by D1 Cap... |
| 18.03.2020 | Sight Sciences Announces $30M Series E Round | MENLO PARK, CA, Sight Sciences announced the closing of an over $30 million Series E Preferred Stock financing round led by D1 Capital Partners. >> Click here for more funding data on Sight Sciences >> To export Sight Scienc... |
| 05.09.2019 | Sight Sciences Raises $56M in Funding | Sight Sciences, Inc., a Menlo Park, Calif.-based medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing. The round was led by KCK Group with participation from MidCap... |
| 04.09.2019 | Sight Sciences raises $31m in Series D funding | Sight Sciences said today that it closed a Series D funding round of more than $30 million. The financing, led by KCK Group, totaled $31 million for the Menlo Park, Calif.-based company that specializes in devices for micro-invasive glaucom... |
| 10.10.2017 | Term Sheet — Tuesday, October 10 | BIG MONEY, FEW DEALS Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? From ExtraHop But here’s the twist. Investors are pumping larger amounts of capital into fewer companies. In other words, a small pe... |
Show more